Trend in global pharmaceutical market: COVID
Prozherina Y.
Ethical aspects of corporate health promotion programs of medical university employees (by the example of COVID-19 prevention)
Zorin K.V., Toporkov V.A., Gurevich K.G., Pustovalov D.A.
Youth labor market trends in the collision with the «new reality» - sanctions and the pandemic (on the example of the professional field «medicine and pharmacy»)
Efimova A.A.
Laboratory monitoring of successful COVID-19 as part of the in-depth medical care project «Healthy Moscow»
Komarov A.G., Latypova M.F., Slutsky E.A., Bezymyanny A.S.
The results of development in the public sector of the Russian pharmaceutical market in 2019-2021
Trofimova E.O., Denisova M.N.
Quality of life in patients with novel coronavirus infection: association with disease severity and change depending on rehabilitation regimens after inpatient treatment
Romanov A.O., Arkhangelskaya A.N., Sharipova M.M., Gurevich K.G.
Scientific substantiation of the possibility of integrated interagency management in countering global biorisks for public health (by the example of the COVID-19 pandemic)
Kaunina D.V., Vasilyev M.D.
Risks in the lifestyle of students
Gureev S.A., Mingazov R.N., Sadykova R.N., Shegurova K.A.
COVID-19 vaccine: seeking salvage
Prozherina Y.
Experience of using surfactant therapy for pneumonia associated withCOVID-19 of obstetric patients
Shvechkova M.V., Kukarskaya I.I., Marchenko R.N., Achmatgaraev V.V., Kukarskaya E.A., Shvechkova A.S.
Clinical trials in the Coronavirus era: management of risks
Vodovozov A.
Surfactant therapy in combination treatment of COVID-19 related acute respiratory distress syndrome
Gubaidullin R.R., Kuzin A.P., Kulakov V.V.
Practice guidelines for the treatment of arterial hypertension in the era of COVID-19: 2020 ISH global hypertension practice review
Vodovozov A.
AnviMax®: optimal drug to combat ARVI and influenza
Kalinina N.
COVID-19: not by vaccine alone
Gandel V.
Elena Artamonova: «Primenenie ingibitorov CDK4/6 v kombinatsiis gormonoterapiey pozvolilo dvukratno uvelichit' prodolzhitel'nost' zhizni patsientok s HR+/HER2-mRMZh»
Article E.
Inhaled surfactant in patients with COVID-19 who took high-flow oxygen therapy: the results of a retrospective analysis
Averyanov A.V., Klypa T.V., Balionis O.I., Bychinin M.V., Chernyak A.V., Troitskiy A.V.
Farma vo vremya pandemii. Ekspertnoe mnenie
Article E.
Reyting aptechnykh setey Rossiipo itogam 1-go polugodiya 2020 goda
Bespalov N., Rasshchupkin P.
Pharmacy retail in the age of pandemic
Kalinina N.
Frantsiya i Kitay nachali klinicheskie ispytaniya preparatov protiv COVID-19
Article E.
Na rasstoyanii vytyanutoy ruki, ilikak farmkompanii menyayut sistemu prodvizheniya
Kuminova E.
1 - 22 of 22 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1


Phone: +7(495) 917-48-86

Principal Contact

Sherstneva Elena Vladimirovna
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies